Reciprocal, temporal expression of speA and speB by invasive M1T1 group A streptococcal isolates in vivo

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 4988-4995

  Kazmi, S U ^a   Kansal, R ^a   Aziz, R K ^a   Hooshdaran, M ^a   Norrby Teglund, A ^a   Low, D E ^a   Halim, A B ^a   Kotb, M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; PROTEIN SMEZ; PROTEIN SPEA; PROTEIN SPEB; PROTEIN SPEF; PROTEIN SPEG; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS GROUP A;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CYSTEINE ENDOPEPTIDASES; EXOTOXINS; FEMALE; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; POLYTETRAFLUOROETHYLENE; STREPTOCOCCUS PYOGENES;

EID: 0034926023     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.4988-4995.2001     Document Type: Article

References (49)

1. Molecular analysis of the capsule gene region of group A Streptococcus: The hasAB genes are sufficient for capsule expression
2. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection
3. Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity
4. Characterization of a two-component system in Streptococcus pyogenes which is involved in regulation of hyaluronic acid production
5. Role of emm and mrp genes in the virulence of group A streptococcal isolate 64/14 in a mouse model of skin infection
6. Induction of lysogenic bacteriophage and phage-associated toxin from group A streptococci during coculture with human pharyngeal cells
7. Genetic relatedness and superantigen expression of M type I group A streptococcal isolates from severe and nonsevere invasive disease
8. Effects of environmental factors on streptococcal erythrogenic toxin A (SPE A) production by Streptococcus pyogenes
9. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections
10. Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion
11. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
12. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci
13. Pathogenesis of group A streptococcal infections
14. A response regulator that represses transcription of several virulence operons in the group A streptococcus
15. Microbiological features of current virulent strains of group A streptococci
16. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B
17. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988 to 1989
18. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases
19. Bacterial pyrogenic exotoxins as superantigens
20. Role of superantigens in the pathogenesis of infectious diseases and their sequelae
21. Superantigens of gram-positive bacteria: Structure-function analyses and their implications for biological activity
22. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A streptococcus
23. Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins
24. The reemergence of severe group A streptococcal disease: An evolutionary perspective
25. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcuspyogenes
26. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies
27. Invasive group A streptococcal disease in The Netherlands: Evidence for a protective role of anti-exotoxin A antibodies
28. Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: Genetic relatedness and production of pyrogenic exotoxins A and B
29. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome
30. Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus
31. Role of mga in growth phase regulation of virulence genes of the group A streptococcus
32. Regulation of mga transcription in the group A streptococcus: Specific binding of mga within its own promoter and evidence for a negative regulator
33. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity, and pyrogenic exotoxin expression
34. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints
35. An experimental model for acute poststreptococcal glomerulonephritis in mice
36. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: Implications for therapeutic efficacy
37. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens
38. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections
39. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease
40. Positive transcriptional control of mry regulates virulence in the group A streptococcus
41. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes
42. The group A streptococcal dipeptide permease (Dpp) is involved in the uptake of essential amino acids and affects the expression of cysteine protease
43. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome
44. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes
45. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment
46. The toxins of group A streptococcus, the flesh eating bacteria
47. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
48. Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and M protein
49. Temperature regulation of the streptococcal pyrogenic exotoxin A-encoding gene (speA)